Sponsor pipeline

Avidity Biosciences, Inc. clinical trial pipeline

Get alerts when Avidity Biosciences, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
2
Phase 3
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07587242 A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as… Muscular Dystrophies Recruiting 2026-10-13
NCT07038200 A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD Facioscapulohumeral Muscular Dystrophy Recruiting 2026-07-27
NCT07008469 Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 Myotonic Dystrophy Type 1 Enrolling by Invitation 2026-08-19
Phase 2
NCT06244082 Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With… DMD Active, Not Recruiting 2026-07-30
NCT06547216 Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral… FSHD Active, Not Recruiting 2026-07-14

Disease areas by active trials

Duchenne Muscular Dystrophy (2)

Get alerts when Avidity Biosciences, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free